Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis. | bioRxiv | 2023 | 37693528 | PubTator, text mining | PubMed |
| Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients. | Int J Mol Sci | 2023 | 37685851 | PubTator, text mining | PubMed |
| A strategy for Cas13 miniaturization based on the structure and AlphaFold. | Nat Commun | 2023 | 37684268 | PubTator, text mining | PubMed |
| A full repertoire of Hemiptera genomes reveals a multi-step evolutionary trajectory of auto-RNA editing site in insect Adar gene. | RNA Biol | 2023 | 37676051 | PubTator, text mining | PubMed |
| Chemical Modifications in RNA: Elucidating the Chemistry of dsRNA-Specific Adenosine Deaminases (ADARs). | Acc Chem Res | 2023 | 37665999 | PubTator, text mining | PubMed |
| Adenosine deaminase acting on RNA 1 (ADAR1) as crucial regulators in cardiovascular diseases: structures, pathogenesis, and potential therapeutic approach. | Front Pharmacol | 2023 | 37663249 | PubTator, text mining | PubMed |
| Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37638324 | PubTator, text mining | PubMed |
| Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer. | Front Immunol | 2023 | 37638051 | PubTator, text mining | PubMed |
| In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds. | Int J Mol Sci | 2023 | 37628792 | PubTator, text mining | PubMed |
| Examination of Factors Affecting Site-Directed RNA Editing by the MS2-ADAR1 Deaminase System. | Genes (Basel) | 2023 | 37628635 | PubTator, text mining | PubMed |
| Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD. | J Physiol Biochem | 2023 | 37620598 | PubTator, text mining | PubMed |
| Regulation of coronavirus nsp15 cleavage specificity by RNA structure. | PLoS One | 2023 | 37616296 | PubTator, text mining | PubMed |
| The hidden RNA code: implications of the RNA epitranscriptome in the context of viral infections. | Front Genet | 2023 | 37614818 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia. | MedComm (2020) | 2023 | 37576864 | PubTator, text mining | PubMed |
| Integrative single-cell analysis of cardiac and pulmonary sarcoidosis using publicly available cardiac and bronchoalveolar lavage fluid sequencing datasets. | Front Cardiovasc Med | 2023 | 37576111 | PubTator, text mining | PubMed |
| Role of microRNAs in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2023 | 37569845 | PubTator, text mining | PubMed |
| Molecular mechanisms of multi-omic regulation in breast cancer. | Front Oncol | 2023 | 37564937 | PubTator, text mining | PubMed |
| Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease. | PLoS One | 2023 | 37549144 | PubTator, text mining | PubMed |
| Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS. | Front Endocrinol (Lausanne) | 2023 | 37547318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=9